An emergency use authorization request for the COVID-19 vaccine developed by Pfizer and BioNTech was expected to be filed with the FDA on Friday, the US government and BioNTech’s co-founder said. This type of Food and Drug Administration authorization is temporary or…
Source: NewsMax
